{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:34:57Z","timestamp":1758638097888,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1245\/s10434-022-12099-7","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:13:44Z","timestamp":1657026824000},"page":"7705-7712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation"],"prefix":"10.1245","volume":"29","author":[{"given":"Mara A.","family":"Piltin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth B.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3228","authenticated-orcid":false,"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"12099_CR1","volume":"2012","author":"K Lambert","year":"2012","unstructured":"Lambert K, Patani N, Mokbel K. Ductal carcinoma in situ: recent advances and future prospects. Int J Surg Oncol. 2012;2012:347385.","journal-title":"Int J Surg Oncol."},{"issue":"1","key":"12099_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin."},{"issue":"41","key":"12099_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):139\u201341.","journal-title":"J Natl Cancer Inst Monogr."},{"issue":"8","key":"12099_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","volume":"150","author":"Y Sagara","year":"2015","unstructured":"Sagara Y, Mallory MA, Wong S, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg. 2015;150(8):739\u201345.","journal-title":"JAMA Surg."},{"issue":"21","key":"12099_CR5","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853\u2014a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381\u20137.","journal-title":"J Clin Oncol."},{"issue":"10","key":"12099_CR6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0959-8049(97)00137-8","volume":"33","author":"M Amichetti","year":"1997","unstructured":"Amichetti M, Caffo O, Richetti A, et al. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. Eur J Cancer. 1997;33(10):1559\u201365.","journal-title":"Eur J Cancer."},{"issue":"3","key":"12099_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open. 2019;9(3):e026797.","journal-title":"BMJ Open."},{"key":"12099_CR8","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS17-OT3-07-01","author":"J Wesseling","year":"2018","unstructured":"Wesseling J, Tryfonidis K. Abstract OT3-07-01: Update of the randomized, non-inferiority LORD trial testing safety of active surveillance for women with screen-detected low-risk ductal carcinoma in situ (EORTC-1401-BCG\/BOOG 2014\u201304, DCIS). Cancer Res. 2018. https:\/\/doi.org\/10.1158\/1538-7445.SABCS17-OT3-07-01.","journal-title":"Cancer Res."},{"issue":"16","key":"12099_CR9","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS Trial. Eur J Cancer. 2015;51(16):2296\u2013303.","journal-title":"Eur J Cancer."},{"issue":"1","key":"12099_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology. 2011;260(1):119\u201328.","journal-title":"Radiology."},{"issue":"12","key":"12099_CR11","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","volume":"24","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ, Ryser MD, Patridge AH, et al. Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol. 2017;24(12):3534\u201340.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"12099_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","volume":"19","author":"WJ Gradishar","year":"2021","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines\u00ae insights: breast cancer, version 4.2021. J Natl Compr Canc Netw. 2021;19(5):484\u201393.","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"12099_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4048\/jbc.2017.20.3.217","volume":"20","author":"S Zahoor","year":"2017","unstructured":"Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217\u201327.","journal-title":"J Breast Cancer."},{"issue":"24","key":"12099_CR14","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","volume":"10","author":"JW Jakub","year":"2017","unstructured":"Jakub JW, Murphy BL, Gonzalez AB, et al. A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease. Ann Surg Oncol. 2017;24(10):2915\u201324.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"12099_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/bjs.11110","volume":"106","author":"A Karakatsanis","year":"2019","unstructured":"Karakatsanis A, Hersi A-F, Pistiolis L, et al. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot Study). Br J Surg. 2019;106(6):720\u20138.","journal-title":"Br J Surg."},{"key":"12099_CR16","unstructured":"Wilke LG, et al. Consensus Guidelines on the Management of the Axilla in Patients with Invasive \/ In Situ Breast Cancer. American Society of Breast Surgeons. 2019. https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-the-Management-o f-the-Axilla.pdf?v2. Accessed 16 February 2022."},{"key":"12099_CR17","doi-asserted-by":"crossref","unstructured":"ASCO guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer: guideline summary. J Oncol Pract. 2005;1(4):134\u20136.","DOI":"10.1200\/jop.2005.1.4.134"},{"issue":"5","key":"12099_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(5):561\u20134.","journal-title":"J Clin Oncol."},{"issue":"27","key":"12099_CR19","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1200\/JCO.21.00934","volume":"39","author":"M Brackstone","year":"2021","unstructured":"Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer: Ontario health (Cancer Care Ontario) and ASCO guideline. J Clin Oncol. 2021;39(27):3056\u201382.","journal-title":"J Clin Oncol."},{"issue":"6","key":"12099_CR20","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.amjsurg.2018.12.069","volume":"217","author":"WW Sheaffer","year":"2019","unstructured":"Sheaffer WW, Gray RJ, Wasif N, et al.\u00a0 Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy. Am J Surg. 2019;217(6):1025\u20139.","journal-title":"Am J Surg."},{"issue":"1","key":"12099_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1245\/s10434-013-3239-4","volume":"21","author":"L Chin-Lenn","year":"2014","unstructured":"Chin-Lenn L, Mack LA, Temple W, et al. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg Oncol. 2014;21(1):66\u201373.","journal-title":"Ann Surg Oncol."},{"key":"12099_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.amjsurg.2006.01.019","volume":"191","author":"A Katz","year":"2006","unstructured":"Katz A, Gage I, Evans S, et al. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2006;191(6):761\u20136.","journal-title":"Am J Surg."},{"issue":"3","key":"12099_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10549-016-3783-2","volume":"156","author":"LM van Roozendaal","year":"2016","unstructured":"van Roozendaal LM, Goorts B, Klinkert M, et al. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat. 2016;156(3):517\u201325.","journal-title":"Breast Cancer Res Treat."},{"issue":"9","key":"12099_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ciresp.2020.10.020","volume":"99","author":"A Bouz\u00f3n Alejandro","year":"2021","unstructured":"Bouz\u00f3n Alejandro A, Iglesias L\u00f3pez \u00c1, Acea Nebril B, Garc\u00eda Jim\u00e9nez ML, D\u00edaz Carballada CC, Varela Romero JR. Underestimation of invasive breast carcinoma in patients with initial diagnosis of ductal carcinoma in situ: size matters. Cir Esp (Engl Ed). 2021;99(9):655\u20139.","journal-title":"Cir Esp (Engl Ed)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12099-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12099-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12099-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T22:11:13Z","timestamp":1665439873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12099-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12099"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12099-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest or sources of funding to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}